Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 3024 (LINC03024) is a human gene encoding a long non-coding RNA molecule that is located in a region of the genome not overlapping protein-coding genes[1][3]. LINC03024 belongs to the family of long intergenic non-coding RNAs (lincRNAs), a subclass of lncRNAs, which are increasingly recognized for their involvement in gene regulatory functions such as epigenetic modulation, chromatin remodeling, and transcriptional regulation[5][7]. However, as of now, there is no direct evidence in the literature that LINC03024 is involved in specific biological pathways, disease processes, or considered a therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 3024 (LINC03024).